Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease
| Main Authors: | , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2008
|
| _version_ | 1797104939342757888 |
|---|---|
| author | Bekker, P Hamilton, G Johnson, D Keshav, S Schall, T |
| author_facet | Bekker, P Hamilton, G Johnson, D Keshav, S Schall, T |
| author_sort | Bekker, P |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T06:40:28Z |
| format | Conference item |
| id | oxford-uuid:f91b4db4-be1e-4a21-83b5-1616afa21ded |
| institution | University of Oxford |
| last_indexed | 2024-03-07T06:40:28Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:f91b4db4-be1e-4a21-83b5-1616afa21ded2022-03-27T12:55:21ZTraficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's diseaseConference itemhttp://purl.org/coar/resource_type/c_5794uuid:f91b4db4-be1e-4a21-83b5-1616afa21dedSymplectic Elements at Oxford2008Bekker, PHamilton, GJohnson, DKeshav, SSchall, T |
| spellingShingle | Bekker, P Hamilton, G Johnson, D Keshav, S Schall, T Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease |
| title | Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease |
| title_full | Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease |
| title_fullStr | Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease |
| title_full_unstemmed | Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease |
| title_short | Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease |
| title_sort | traficet en an oral ccr9 specific antagonist induces high levels of remission in the open label phase of protect 1 in crohn s disease |
| work_keys_str_mv | AT bekkerp traficetenanoralccr9specificantagonistinduceshighlevelsofremissionintheopenlabelphaseofprotect1incrohnsdisease AT hamiltong traficetenanoralccr9specificantagonistinduceshighlevelsofremissionintheopenlabelphaseofprotect1incrohnsdisease AT johnsond traficetenanoralccr9specificantagonistinduceshighlevelsofremissionintheopenlabelphaseofprotect1incrohnsdisease AT keshavs traficetenanoralccr9specificantagonistinduceshighlevelsofremissionintheopenlabelphaseofprotect1incrohnsdisease AT schallt traficetenanoralccr9specificantagonistinduceshighlevelsofremissionintheopenlabelphaseofprotect1incrohnsdisease |